Exploring How Antibody Format Drives Clearance from the Brain
- 26 July 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 21 (9) , 4416-4429
Abstract
Monoclonal antibodies (mAbs) have high binding specificity and affinity, making them attractive for treating brain diseases. However, their effectiveness is limited by poor blood-brain barrier (BBB) penetration and rapid central nervous system (CNS) clearance. Our group identified blood-brain barrier modulator (BBBM) peptides that improved mAb penetration across the BBB into the brain. In this study, we investigated the pharmacokinetics of a mAb delivered to the brain using BBBMs after intravenous (IV) administration and explored the impact of antibody format (size, neonatal Fc receptor (FcRn) binding, hyaluronic acid binding) on brain clearance following direct injection into the central nervous system (CNS) via intracerebroventricular (ICV) injection. IRDye800CW-labeled antibodies were administered into C57BL/6 mice via ICV or IV injection, and organ concentrations were measured after various time points. When a mAb was coadministered with a BBBM peptide, the permeation of mAb across the BBB was increased compared to mAb alone at early time points; however, the mAb was cleared within 2 h from the brain. ICV experiments revealed that an antibody Fab fragment had a higher brain exposure than a mAb, and that a Fab fused to a hyaluronic acid binding domain (Fab-VG1) showed remarkable improvement in brain exposure. These findings suggest that BBBMs and antibody format optimization may be promising strategies for enhancing brain retention of therapeutic antibodies.Keywords
Funding Information
- Genentech
- National Institute on Aging (R01-AG082273)
- Pharmaceutical Research and Manufacturers of America Foundation
- National Institute of General Medical Sciences (T32-GM008359)
This publication has 44 references indexed in Scilit:
- Matters of size: Roles of hyaluronan in CNS aging and diseaseAgeing Research Reviews, 2021
- An optimized intracerebroventricular injection of CD4+ T cells into miceSTAR Protocols, 2021
- A translational platform PBPK model for antibody disposition in the brainJournal of Pharmacokinetics and Pharmacodynamics, 2019
- Probing the importance of clonality: Single cell subcloning of clonally derived CHO cell lines yields widely diverse clones differing in growth, productivity, and product qualityBiotechnology Progress, 2017
- Residualization Rates of Near-Infrared Dyes for the Rational Design of Molecular Imaging AgentsMolecular Imaging and Biology, 2015
- Modulation of Intercellular Junctions by Cyclic-ADT Peptides as a Method to Reversibly Increase Blood–Brain Barrier PermeabilityJournal of Pharmaceutical Sciences, 2015
- Efflux of monoclonal antibodies from rat brain by neonatal Fc receptor, FcRnBrain Research, 2013
- Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and humanJournal of Pharmacokinetics and Pharmacodynamics, 2011
- Blood–brain barrier deliveryDrug Discovery Today, 2007
- Mediated efflux of IgG molecules from brain to blood across the blood–brain barrierJournal of Neuroimmunology, 2001